Dynamics of SARS-CoV-2 Variants of Concern in Vaccination Model City in the State of Sao Paulo, Brazil

Author:

Slavov Svetoslav NanevORCID,de La-Roque Debora Glenda Lima,da Costa Pericles Natan Mendes,Rodrigues Evandra StrazzaORCID,Santos Elaine Vieira,Borges Josiane Serrano,Evaristo Mariane,de Matos Maçonetto Juliana,Marques Adriana Aparecida,Milhomens Jonathan,Rós Felipe AugustoORCID,Fonseca VagnerORCID,Lima Alex Ranieri Jerônimo,Ribeiro Gabriela,Lima Loyze Paola Oliveira de,Garibaldi Pedro Manuel Marques,Ferreira Natasha Nicos,Moraes Glenda Renata,Marqueze Elaine CristinaORCID,Barros Claudia Renata dos SantosORCID,Martins Antonio Jorge,Coutinho Luiz Lehmann,Calado Rodrigo Tocantins,Borges Marcos,Elias Maria CarolinaORCID,Sampaio Sandra Coccuzzo,Giovanetti MartaORCID,Alcantara Luiz Carlos Junior,Covas Dimas Tadeu,Kashima Simone

Abstract

From a country with one of the highest SARS-CoV-2 morbidity and mortality rates, Brazil has implemented one of the most successful vaccination programs. Brazil’s first model city vaccination program was performed by the CoronaVac vaccine (Sinovac Biotech) in the town of Serrana, São Paulo State. To evaluate the vaccination effect on the SARS-CoV-2 molecular dynamics and clinical outcomes, we performed SARS-CoV-2 molecular surveillance on 4375 complete genomes obtained between June 2020 and April 2022 in this location. This study included the period between the initial SARS-CoV-2 introduction and during the vaccination process. We observed that the SARS-CoV-2 substitution dynamics in Serrana followed the viral molecular epidemiology in Brazil, including the initial identification of the ancestral lineages (B.1.1.28 and B.1.1.33) and epidemic waves of variants of concern (VOC) including the Gamma, Delta, and, more recently, Omicron. Most probably, as a result of the immunization campaign, the mortality during the Gamma and Delta VOC was significantly reduced compared to the rest of Brazil, which was also related to lower morbidity. Our phylogenetic analysis revealed the evolutionary history of the SARS-CoV-2 in this location and showed that multiple introduction events have occurred over time. The evaluation of the COVID-19 clinical outcome revealed that most cases were mild (88.9%, 98.1%, 99.1% to Gamma, Delta, and Omicron, respectively) regardless of the infecting VOC. In conclusion, we observed that vaccination was responsible for reducing the death toll rate and related COVID-19 morbidity, especially during the gamma and Delta VOC; however, it does not prevent the rapid substitution rate and morbidity of the Omicron VOC.

Funder

São Paulo Research Foundation

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference34 articles.

1. Coronavirus Brasil

2. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence

3. Incidence of SARS-CoV-2 over four epidemic waves in a low-resource community in Rio de Janeiro, Brazil: A prospective cohort study

4. Brazilian Town Experiment Shows Mass Vaccination Can Wipe Out COVID-19 https://www.science.org/content/article/brazilian-town-experiment-shows-mass-vaccination-can-wipe-out-covid-19

5. FastQC: A Quality Control Tool for High Throughput Sequence Data [Online] http://www.bioinformatics.babraham.ac.uk/projects/fastqc/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3